| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From UCLA Neurology, Los Angeles, CA.
Address correspondence and reprint requests to Dr. Joanna Jen, UCLA Neurology, 710 Westwood Plaza, Los Angeles, CA 90095-1769; e-mail: jjen{at}ucla.edu
The authors searched for mutations in CACNA1A in patients with episodic ataxia and describe the clinical spectrum in genetically defined patients. Eighteen families and nine sporadic cases of episodic ataxia were evaluated for mutations in CACNA1A. The families were first genotyped to check for linkage to the chromosome 19p locus of CACNA1A. In families consistent with linkage and in the sporadic cases, the authors screened for polymorphisms in CACNA1A using single-strand conformational polymorphism and denaturing high performance liquid chromatography followed by direct sequencing to identify specific nucleotide changes. Of the 18 families, 11 were linked to 19p and mutations were found in 9. Mutations were detected in four of the nine sporadic cases. Overall, five nonsense mutations, four missense mutations, two deletions, one insertion, and one donor splice mutation were identified. All but two of the 64 genetically defined patients reported episodes of ataxia (two members of one family only had progressive ataxia). All but one had onset before age 20 and all but four had interictal nystagmus. Migraine headaches occurred in more than half, and about two thirds reported a good response to treatment with acetazolamide. Vertigo and weakness accompanied the ataxia in more than half of the genetically defined patients. One family had multiple members with epilepsy. A wide range of mutations in CACNA1A were associated with episodic ataxia. Four of 13 were missense mutations; the remainder predicted truncated proteins. The mutations were scattered throughout the gene, and only 2 of the 13 mutations identified in our laboratory have been reported by other laboratories, so it will not be possible to screen a few "hot spots" in CACNA1A. Overall, the type of mutation, missense versus nonsense, or the location of altered or truncated amino acid residues did not predict the clinical phenotype.
Received May 30, 2003. Accepted in final form September 17, 2003.
Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the January 13 issue to find the title link for this article.
This article has been cited by other articles:
|
|
 |
|
  F. Riant, R. Mourtada, P. Saugier-Veber, and E. Tournier-Lasserve Large CACNA1A Deletion in a Family With Episodic Ataxia Type 2 Arch Neurol, June 1, 2008; 65(6): 817 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y H Cha, H Lee, J C Jen, J C Kattah, S F Nelson, and R W Baloh Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1273 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.C. Jen, T.D. Graves, E.J. Hess, M.G. Hanna, R.C. Griggs, R.W. Baloh, and the CINCH investigators Primary episodic ataxias: diagnosis, pathogenesis and treatment Brain, October 1, 2007; 130(10): 2484 - 2493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. L. Thomsen, M. Kirchmann, A. Bjornsson, H. Stefansson, R. M. Jensen, A. C. Fasquel, H. Petursson, M. Stefansson, M. L. Frigge, A. Kong, et al. The genetic spectrum of a population-based sample of familial hemiplegic migraine Brain, February 1, 2007; 130(2): 346 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.D. Graves Ion channels and epilepsy QJM, April 1, 2006; 99(4): 201 - 217. [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Jeng, Y.-T. Chen, Y.-W. Chen, and C.-Y. Tang Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2 Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1209 - C1220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Imbrici, L. H. Eunson, T. D. Graves, K. P. Bhatia, N. H. Wadia, D. M. Kullmann, and M. G. Hanna Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A Neurology, September 27, 2005; 65(6): 944 - 946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Jen, J. Wan, T. P. Palos, B. D. Howard, and R. W. Baloh Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures Neurology, August 23, 2005; 65(4): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Eunson, T. D. Graves, and M. G. Hanna New calcium channel mutations predict aberrant RNA splicing in episodic ataxia Neurology, July 26, 2005; 65(2): 308 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Wan, R. Khanna, M. Sandusky, D. M. Papazian, J. C. Jen, and R. W. Baloh CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics Neurology, June 28, 2005; 64(12): 2090 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Hanna, T. D. Graves, S. Jaffe, P. Imbrici, D. M. Kullmann, and on behalf of the authors Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia--authors' response Brain, June 1, 2005; 128(6): E33 - E33. [Full Text] [PDF]
|
|
|
|
|
|
S. D. Spacey, L. A. Materek, B. I. Szczygielski, and T. D. Bird Two Novel CACNA1A Gene Mutations Associated With Episodic Ataxia Type 2 and Interictal Dystonia Arch Neurol, February 1, 2005; 62(2): 314 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Imbrici, S. L. Jaffe, L. H. Eunson, N. P. Davies, C. Herd, R. Robertson, D. M. Kullmann, and M. G. Hanna Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia Brain, December 1, 2004; 127(12): 2682 - 2692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Strupp, R. Kalla, M. Dichgans, T. Freilinger, S. Glasauer, and T. Brandt Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine Neurology, May 11, 2004; 62(9): 1623 - 1625. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
